[European topic: liver surgery II--regional chemotherapy].
The most important methods of regional chemotherapy are exemplified by 657 cases of primary and secondary liver only malignancies. I. Adjuvant portal therapy of the liver with resection of the colorectal primary malignancy seems to be advantageous for advanced tumors. II. It is still unresolved whether survival is prolonged by adjuvant treatment of the liver following curative resection of colorectal liver metastases. III. The median survival time (FUDR, pump) is 17 months for palliative local chemotherapy of unresectable colorectal liver metastases. IV. Primary non-resectable liver malignancies show the best results after chemoembolisation (Frankfurt method).
Hottenrott
C
C
Chirurgische Universitätsklinik Frankfurt.
Lorenz
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D005467:Floxuridine / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007260:Infusion Pumps; D007261:Infusions, Intra-Arterial / Q000295:instrumentation*; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary* / Q000601:surgery; D016685:Mitomycin / Q000008:administration & dosage
D005467:Floxuridine; D016685:Mitomycin; D005472:Fluorouracil
Europäisches Thema: Leberchirurgie II--Regionale Chemotherapie.